FY2023
Effective from
- Added
Immune-mediated heparin-induced thrombocytopenia
Billable diagnosis code
CDC/NCHS · FY2023code, if applicable, for adverse effect of heparin (T45.515-)
Coverage depends on the payer, service and applicable policy. A billable code does not guarantee payment.
For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗First observed · 2022-10-01
Latest recorded change · FY2023
Effective from
Immune-mediated heparin-induced thrombocytopenia
Billable diagnosis code
CDC/NCHS · FY2023| All editions | Effective from | Code history |
|---|---|---|
| FY2023 | 2022-10-01 | Added |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
code, if applicable, for adverse effect of heparin (T45.515-)
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Previous assignment: D75.82
Other entries in the same category; these are not automatic substitutes.
| Code | Description | Category · further specificity required |
|---|---|---|
| D75.821 | Non-immune heparin-induced thrombocytopenia | Billable / specific |
| D75.828 | Other heparin-induced thrombocytopenia syndrome | Billable / specific |
| D75.829 | Heparin-induced thrombocytopenia, unspecified | Billable / specific |
Official titles and instructions are preserved in their source language. Official sources ↗